chr1-151760061-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_031420.4(MRPL9):c.793C>T(p.Pro265Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000781 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_031420.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL9 | NM_031420.4 | c.793C>T | p.Pro265Ser | missense_variant | 7/7 | ENST00000368830.8 | NP_113608.1 | |
MRPL9 | NM_001300733.2 | c.691C>T | p.Pro231Ser | missense_variant | 6/6 | NP_001287662.1 | ||
MRPL9 | NR_125331.2 | n.850C>T | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL9 | ENST00000368830.8 | c.793C>T | p.Pro265Ser | missense_variant | 7/7 | 1 | NM_031420.4 | ENSP00000357823 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251092Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135728
GnomAD4 exome AF: 0.0000780 AC: 114AN: 1461622Hom.: 0 Cov.: 30 AF XY: 0.0000715 AC XY: 52AN XY: 727078
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74464
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at